Global Health Ltd

Know More
NSEBSE

1487.050.80 (0.05%)

12:00 AM,23rd Feb 2024

1484.95-15.05 (-1.00%)

12:00 AM,23rd Feb 2024

BSE : 543654

NSE : MEDANTA

Sector : Health care

ISIN Code : INE474Q01031

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Feb 23 2024 | 12:00 AM IST

Market Cap (₹ Cr)

39919

Turnover (₹ Cr)

6.14

Volume (Shares)

413092

Face Value

2

52-WK High

1513.90

52-WK High Date

16 Feb 2024

52-WK Low

464.30

52-WK Low Date

28 Mar 2023

All Time High

1513.90

All Time High Date

16 Feb 2024

All Time Low

390.55

All Time Low Date

16 Nov 2022

Global Health Ltd

Global Health Limited (GHL) was incorporated as `Global Health Private Limited' on August 13 2004 at New Delhi India as a Private Limited Company. The Company converted into a Public Limited Company and name of the Company was changed to `Global Health Limited' dated August 11 2021 issued by the RoC. Presently the Company is engaged in the business of providing healthcare services.The Company was founded by Dr. Naresh Trehan a world-renowned cardiovascular and cardiothoracic surgeon. The Company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science neurosciences oncology digestive and hepatobiliary sciences orthopaedics liver transplant and kidney and urologoly. Under the Medanta brand it has a network of 5 hospitals currently in operation including Gurugram Indore Ranchi Lucknow and Patna and one hospital in Noida which is under construction. As at June 30 2022 the Company provide healthcare services in over 30 medical specialties and is engaged over 1300 doctors led by experienced department heads and spanning an area of 4.7 million sq. ft. their operational hospitals have 2467 installed beds to serve Indian and international patients.In November 2009 the Company opened its flagship hospital in Gurugram. In 2015 its subsidiary Global Health Patliputra Private Limite (GHPPL) entered into a Concession Agreement with Governor of Bihar for the development operation and maintenance of a proposed hospital on public-private partnership at Patna.In 2019 it commenced operations of new hospital at Lucknow.In 2020 Patna hospital's outpatient department facility was launched and the inpatient department facility of its Patna hospital was inaugurated in October 2021 which commenced operations during year 2022. The Company has taken in-house facility and operate pharmacies at its Gurugram Lucknow Indore and Ranchi hospitals as well as launched an outpatient department pharmacy at South Delhi clinic in year 2021 and launched outpatient department pharmacy at South Delhi clinic at Patna hospital in year 2022. As at June 30 2022 it had 200 installed beds and employed over 50 doctors across key specialties such as neuroscience and cardiac sciences. Patna hospital had 228 installed beds and employed over 125 doctors as at June 30 2022 and is designed to accommodate over 500 beds. In the Board Meeting dated 25 January 2021 the Board of Directors of the Holding Company have approved capital raising comprising of fresh issue and offer for sale of equity shares by the existing shareholders through an Initial Public Offering (IPO)The Company came out with a public issue during November 2022 by raising Rs. 2205.57 crores through fresh issue amounting to Rs. 500 crores and offer for sale amounting to Rs. 1705.57 crores.The Company's Lucknow hospital added 191 beds in FY23 including over 90 critical care beds. Lucknow Hospital further added 7 new OTs and have hired over 50 senior clinicians. Towards the end of FY 2023 Lucknow Hospital commissioned the Siemens Varian EDGE Radiation Oncology machine - the first in North India - as well as set up a dedicated e-ICU Command Centre to assist in remote critical care management. The Company's Patna hospital added over 100 beds and 35+ doctors in FY23. In FY23 the Company introduced a new 300- bed hospital project in Indore. It started Medanta Labs in January 2023. During the year 2022-23 GHL Pharma was incorporated as a wholly-owned subsidiary on June 29 2022.

Global Health Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

39919

EPS - TTM (₹) [C]

16.83

P/E Ratio (X) [C]

15.04

Face Value (₹) 2
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [C]98.88
P/B Ratio (₹) [C]15.04
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
HDFC Retirement Savings Fund-Hybrid Debt (G) 0.70 5000 0.45
HDFC Retirement Savings Fund-Hybrid Debt-Dir (G) 0.70 5000 0.45
Groww Nifty Total Market Index Fund-Regular (G) 0.08 543 0.08
Groww Nifty Total Market Index Fund-Direct (G) 0.08 543 0.08

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

1351.00

1509.90

Week Low/High

1351.00

1514.00

Month Low/High

1081.10

1514.00

Year Low/High

464.30

1514.00

All time Low/High

391.05

1514.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week3.68%3.58%1.290.78%
1 Month31.28%31.54%4.244.59%
3 Month65.61%65.55%11.1212.17%
6 Month109.74%109.92%12.1114.24%
1 Year201.76%202.12%23.0726.85%
3 Year%%47.4551.03%

Company Info

Company Information

Registered Office: Medanta-Mediclinic, E-18 Defence Colony,New Delhi,New Delhi-110024 Ph: 91-124-4834060

Email:compliance@medanta.org

URL:http://www.medanta.org